| Aarti Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524348 |
NSE Symbol : AARTIDRUGS |
P/E(TTM) : 22.04 |
|
ISIN Demat : INE767A01016 |
Div & Yield% : 0.48 |
EPS(TTM) : 18.95 |
|
Book Value(₹) : 153.92 |
Market Cap(₹Cr) : 3,811.44 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 627.45 | 631.68 | 528.80 | 578.95 | 520.96 | 622.96 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 627.45 | 631.68 | 528.80 | 578.95 | 520.96 | 622.96 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.20 | 0.83 | 1.22 | 0.15 | 0.39 | 1.71 |
| Total Income | 627.65 | 632.51 | 530.02 | 579.10 | 521.35 | 624.67 |
| Total Expenditure | 537.64 | 552.40 | 486.49 | 503.76 | 457.01 | 534.31 |
| PBIDT | 90.01 | 80.11 | 43.53 | 75.34 | 64.34 | 90.36 |
| Interest | 6.95 | 6.59 | 6.95 | 6.01 | 6.82 | 7.48 |
| PBDT | 83.06 | 73.52 | 36.58 | 69.33 | 57.52 | 82.88 |
| Depreciation | 15.21 | 14.95 | 14.87 | 13.55 | 12.27 | 12.21 |
| Tax | 16.00 | 15.00 | -14.38 | 12.00 | -5.39 | 9.69 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.00 | -1.39 | 2.25 | 2.00 | 2.00 | -0.50 |
| Reported Profit After Tax | 50.85 | 44.96 | 33.84 | 41.78 | 48.64 | 61.48 |
| Extra-ordinary Items | -1.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 52.42 | 44.96 | 33.84 | 41.78 | 48.64 | 61.48 |
| EPS (Unit Curr.) | 5.57 | 4.93 | 3.71 | 4.58 | 5.33 | 6.74 |
| EPS (Adj) (Unit Curr.) | 5.57 | 4.93 | 3.71 | 4.58 | 5.33 | 6.74 |
| Calculated EPS (Unit Curr.) | 5.57 | 4.93 | 3.71 | 4.58 | 5.33 | 6.74 |
| Calculated EPS (Adj) (Unit Curr.) | 5.57 | 4.93 | 3.71 | 4.58 | 5.33 | 6.74 |
| Calculated EPS (Ann.) (Unit Curr.) | 22.29 | 19.70 | 14.83 | 18.31 | 21.32 | 26.94 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 22.29 | 19.70 | 14.83 | 18.31 | 21.32 | 26.94 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 91.27 | 91.27 | 91.27 | 91.27 | 91.27 | 91.27 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 14.35 | 12.68 | 8.23 | 13.01 | 12.35 | 14.50 |
| PBDTM(%) | 13.24 | 11.64 | 6.92 | 11.98 | 11.04 | 13.30 |
| PATM(%) | 8.10 | 7.12 | 6.40 | 7.22 | 9.34 | 9.87 |
